[HTML][HTML] Challenges and opportunities in the application of artificial intelligence in gastroenterology and hepatology

CD Christou, G Tsoulfas - World journal of gastroenterology, 2021 - ncbi.nlm.nih.gov
Artificial intelligence (AI) is an umbrella term used to describe a cluster of interrelated fields.
Machine learning (ML) refers to a model that learns from past data to predict future data …

[HTML][HTML] Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer …

A Bakrania, N Joshi, X Zhao, G Zheng, M Bhat - Pharmacological research, 2023 - Elsevier
Liver cancers are the fourth leading cause of cancer-related mortality worldwide. In the past
decade, breakthroughs in the field of artificial intelligence (AI) have inspired development of …

[HTML][HTML] Bile acids as drivers and biomarkers of hepatocellular carcinoma

S Colosimo, JW Tomlinson - World Journal of Hepatology, 2022 - ncbi.nlm.nih.gov
The prevalence of hepatocellular carcinoma (HCC) is rapidly increasing, driven not least in
part by the escalating prevalence of non-alcoholic fatty liver disease. Bile acid (BA) profiles …

Plasma bile acid profile in patients with and without type 2 diabetes

A Mantovani, A Dalbeni, D Peserico, F Cattazzo… - Metabolites, 2021 - mdpi.com
A paucity of information currently exists on plasma bile acid (BA) profiles in patients with and
without type 2 diabetes mellitus (T2DM). We assayed 14 plasma BA species in 224 patients …

Establishment of a potential serum biomarker panel for the diagnosis and prognosis of cholangiocarcinoma using decision tree algorithms

P Kimawaha, A Jusakul, P Junsawang, R Thanan… - Diagnostics, 2021 - mdpi.com
Potential biomarkers which include S100 calcium binding protein A9 (S100A9), mucin 5AC
(MUC5AC), transforming growth factor β1 (TGF-β1), and angiopoietin-2 have previously …

[HTML][HTML] Artificial intelligence and cholangiocarcinoma: Updates and prospects

H Haghbin, M Aziz - World Journal of Clinical Oncology, 2022 - ncbi.nlm.nih.gov
Artificial intelligence (AI) is the timeliest field of computer science and attempts to mimic
cognitive function of humans to solve problems. In the era of “Big data”, there is an ever …

[PDF][PDF] Generative Artificial Intelligence in (laboratory) medicine: friend or foe?

D Negrini, G Lippi - biochimica clinica, 2023 - biochimicaclinica.it
The artificial intelligence (AI) model ChatGPT, which is capable to generate human-like
responses, has recently raised paramount interest and attention due to its inherent capability …

[HTML][HTML] Novel approaches in search for biomarkers of cholangiocarcinoma

LP Mocan, M Ilieș, CS Melincovici… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Cholangiocarcinoma (CCA) arises from the ductular epithelium of the biliary tree, either
within the liver (intrahepatic CCA) or more commonly from the extrahepatic bile ducts …

Application of AI on cholangiocarcinoma

J Huang, X Bai, Y Qiu, X He - Frontiers in Oncology, 2024 - frontiersin.org
Cholangiocarcinoma, classified as intrahepatic, perihilar, and extrahepatic, is considered a
deadly malignancy of the hepatobiliary system. Most cases of cholangiocarcinoma are …

Circulating bile acids profiles in obese children and adolescents: A possible role of sex, puberty and liver steatosis

M Montagnana, E Danese, A Giontella, S Bonafini… - Diagnostics, 2020 - mdpi.com
Background. Childhood obesity is becoming a major health issue and contributes to
increasing the risk of cardiovascular disease in adulthood. Since dysregulated metabolism …